MedTrace Logo

Omega-3 Fatty Acid Supplementation and Tear Film Quality in Celiac Patients

NCT05825976 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 45

Last updated 2023-04-24

No results posted yet for this study

Summary

The study aims to determine the effectiveness on the tear film quality and symptoms related with dry eye disease in patients with celiac disease.

Conditions

Interventions

DIETARY_SUPPLEMENT

Omega-3 Fatty ACids

Intervention consists of two different doses of omega-3: high concentration (Intervention group 1) and low concentration (Intervention group 2).

OTHER

Control

Supplementation with extra virgin olive oil as a for of positive placebo control.

Sponsors & Collaborators

  • Plava Medical Group, Bosna and Herzegovina

    collaborator UNKNOWN

  • Josip Juraj Strossmayer University of Osijek

    lead OTHER

Principal Investigators

  • Ines Banjari, PhD · Josip Juraj Strossmayer University of Osijek, Faculty of Food Technology, Department of Food and Nutrition Research

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-03-25
Primary Completion
2023-07-01
Completion
2023-08-01

Countries

  • Bosnia and Herzegovina

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05825976 on ClinicalTrials.gov